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Summary: The cholesterol in high density lipoproteins (HDL) has been determined in 140 serum samples after dex-
tran sulfate-magnesium chloride precipitation of the apolipoprotein B-containing lipoproteins. The values correlated
well with simultaneously measured values from preparative ultracentrifugation (slope 0.98, r = 0.93). Furthermore,
there was a significant correlation in 60 specimen between the dextran sulfate-MgC!2 and heparin-MnCl2-precipitation
method.
Dextran sulfate-MgQ2 precipitation allows a precise and reproducible HDL-cholesterol determination (CV from 20
days 2.7 %).
Cholesterin in Lipoproteinen hoher Dichte: Ein Vergleich zwischen Dextransulfat-Magnesiumchloridpräzipitation und
präparativer Ultrazentrifugation
Zusammenfassung: Das Cholesterin in Lipoproteinen hoher Dichte (HOL) wurde in 140 Proben nach Dextransulfat-
Magnesiumchlorid-Fällung der Apolipoprotein B-hältigen Lipoproteine bestimmt. Die gemessenen Werte korrelierten gut
mit den gleichzeitig bestimmten Werten von der präparativen Ultrazentrifuge (Anstieg der Korrelationsgerade 0,98, r =
0,93). Es bestand ebenfalls eine signifikante Korrelation in 60 Proben zwischen der Dextransulfat-MgCl2- und Heparin-
MnCl2-Methode (1,Q3, r = 0,95).
Mit Dextransulfat-MgCl2 ist eine präzise und reproduzierbare HDL-Cholesterinbestimmung möglich (VK von 20
Tagen 2,7 %).
Introduction
HDL1) cholesterol concentration is inversely associated
with the incidence of atherosclerotic coronary heart
disease (1-4). Common methods for measuring HDL
cholesterol are based on polyanioij precipitation of the
lipoproteins that contain apolipoprotein B. Most of the
investigations were performed with heparin-manganese
chloride, and the resulting values showed a good correl-
1 VLDL =very low density lipoproteins, LDL = low density
lipoproteins, HDL = high density lipoproteins.
ation with ultracentrifugal HDL cholesterol values (5,6,7).
Other methods, using dextran sulfate, or sodium phos-
photungstate and magnesium chloride, may be simpler
(8,9). Furthermore, the use of MnCl2 has been criticized
because it results in the production of complexes (10).
To our knowledge there are two reports concerning the
high precision and specificity of the dextran sulfate
method (8,9). The correlation with HDL cholesterol
values after preparative ultracentrifugation has not been
reported. We therefore determined HDL cholesterol
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Tab. 1. Linear regression analysis: HDL cholesterol, ultracentrifugation versus dextran-sulfate-MgC!2 precipitation and dextran sul-

















y-intercept r ± SP
2.86 0.93 ± 0.03X
-0.389 0.95 ± 0.05X
simultaneously with these two methods, and compared
the results with those obtained with the heparin-MnCl2
precipitation method.
Material and Methods
Serum samples were obtained from 140 adults (mean age ± SEM
49 ± 3 years) after an overnight fast. Most of the subjects
(n=112) were hyperlipoproteinemic outpatients. Values for serum
total cholesterol ranged from 3.04 to 20.54 mmol/1 and for
serum triglycerides from 0.94 to 71.78 mmol/1. The fractionation
of serum lipoproteins by preparative ultracentrifugation at den-
sities d < 1.006 g/ml (VLDL separation) and d< 1.063 g/ml
(LDL separation, HDL determination in the bottom fraction)
was performed for all samples as described earlier (11,12). The re-
covery of lipoprotein lipids in VLDL, LDL and HDL was always
within 100 ± 10 % of total serum cholesterol.
For the separation of HDL by dextran sulfate-MgC!2 precipi-
tation the method of Kostner (8) was used: 1 ml of serum was
mixed with 50 μΐ of MgCl2 solution (2 mol/1) and 50 μΐ of a
dextran sulfate 500 solution (20 g/1, Pharmacia, Uppsala,
Sweden), allowed to stand for 5 minutes, and centrifuged (5000 g,
30 min). Cholesterol was determined in the supernate. A correc-
tion factor of 1.1 was used to correct the dilution introduced by
the precipitating solutions. Lipemic sera with serum triglycerides
> 20 mmol/1 were diluted twofold, and those with serum tri-
glycerides > 40 mmol/1 were diluted fourfold. By immuno-
chemical techniques we ascertained that lipoproteins that contain
apolipoprotein B were precipitated quantitatively up to a
serum triglyceride concentration of 80 mmol/1.
A second precipitating method with heparin-MnC!2 for the HDL
separation was simultaneously used for 60 specimens. It was
performed as described in the Lipid Research Clinic Program
(13).
Cholesterol was measured enzymatically (14). The intra-assay
precision of the cholesterol determination was examined with
various volumes of the control serum Precilip (Boehringer, Mann-
heim, West-Germany). The intra-assay and inter-assay precision
of the precipitation method was calculated from 20 determ-
inations of a serum pool. The data are mean values ± SEM. After
linear regression analysis with calculation of the slope and the
y-intercept the significance of the correlation coefficients
(r ± SD) was calculated by the t-test.
Results
As shown in table 1, there was a significant correlation
between the HDL cholesterol values obtained by pre-
parative ultracentrifugation and by dextran sulfate-MgC!2
precipitation. The slope of the linear regression analysis
was 0.98. The comparison between the dextran-MgQ2
and, furthermore, the heparin-MriCl2 precipitation in
60 specimens showed significant correlation, with a
slope of 1.03.
The intra-assay coefficient of variation (CV) for the
dextran-MgC!2 method was 2.3 %. The inter-assay CV of
20 separate days was 2.7 %.
Discussion
The dextran sulfateJMgC!2 technique with subsequent
enzymatic cholesterol assay is highly reproducible; it
allows a satisfactory quantification of HDL cholesterol
and compares well with preparative ultracentrifugation.
In agreement with Kostner (8) we could demonstrate no
apolipoprotein B immunoreactivity in the supernatant;
this shows that apolipoprotein B-containing lipoproteins
are completely precipitated. Lipemic sera must be
diluted as proposed for other precipitation methods (5,7).
For comparable cholesterol concentrations Finley et al.
(9) found a slightly better CV (1.7 %, n = 30) for intra-
assay precision.
There was a good correlation between dextran sulfate-
MgCl2 and heparin-MnC!2 precipitation for HDL separ-
ation. Both methods give comparable results, the heparin-
MnCl2 method must be performed at 4 °£, while the
dextran sulfate-MgC!2 precipitation can be applied at
room temperatures.
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